Access · Shortages

How shortages have affected compounding permissions

Access › Shortages shortage compounding FDA formulary

1 hidden by flag

crossover_reviewTL3Regular26 Jun 2026#1

How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below.

A coverage question with the paperwork detail included, since that is what determines the answer.

Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to submit next, which is the useful thing about a well-written denial.

Before I spend a week on it: is my reading of the stated criterion correct, and is there a documented precedent for this specific ground?

27 likes 1mo

lyophil_marginTL3Regular27 Jun 2026#2

the opening post answers the question as asked. The question underneath it is different.

Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.

5 likes 1mo

c.kuuselaTL2 Moderator28 Jun 2026#3

Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for planning.

0 likes 30d

taper_fileTL3Regular28 Jun 2026#4

Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and time-limited (usually for the duration of the shortage).

29 likes 30d

g.tammTL2 Moderator29 Jun 2026#5

Worth separating two things that the opening post runs together.

Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are different decisions.

21 likes 29d

figure_reviewTL2Member30 Jun 2026#6

crossover_review, post #1: How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. A coverage question with the paperwork detail included, since that is what determines the answer. Denial received, with a stated reason. My reading of the reason is that it tells me exactly what… Go to post

post #5 is right about the mechanism and I think understates the practical bit.

Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your clinician is prudent if the gap is weeks or longer.

9 likes in reply to #1 28d

e.kuipersTL2 Moderator30 Jun 2026#7

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

0 likes 28d

NorringtonTL3Regular1 Jul 2026 · edited#8

Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration discussion with a clinician.

0 likes 27d

b.brandtTL21 Jul 2026#9

Post hidden by community flags

Staff rationale: Hidden by community flags. The claim about a named supplier was not accompanied by a batch, a date, a method or a document, which R6 requires.

Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.

The corresponding entry is in the public moderation log. Hidden posts are never deleted.

cannula_notesTL2Member2 Jul 2026#10

International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is prudent if you can.

1 like in reply to #1 26d

h.brandtTL2 Moderator2 Jul 2026#11

taper_file, post #4: Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and time-limited (usually for the duration of the shortage). Go to post

post #10 is right about the mechanism and I think understates the practical bit.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

17 likes in reply to #4 26d

isotonic_sheetTL3Regular3 Jul 2026 · edited#12

e.kuipers, post #7: Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound. Go to post

Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.

0 likes in reply to #7 25d

p.trevinoTL2 Moderator3 Jul 2026#13

International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is prudent if you can.

1 like 24d

RodriguesTL3Regular4 Jul 2026#14

I read post #12 twice before replying, because I had assumed the opposite.

Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.

7 likes 24d

g.radichTL2 Moderator4 Jul 2026#15

post #14 answers the question as asked. The question underneath it is different.

24 likes in reply to #4 24d

maintenance_modeTL3Regular5 Jul 2026#16

On post #12 — agreed on the reasoning, with one qualification.

Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are different decisions.

0 likes in reply to #7 23d

y.adeyemiTL2 Moderator5 Jul 2026#17

3 likes 23d

r.venkatesanTL3Wiki editor6 Jul 2026 · edited#18

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

11 likes 22d

d.ferreiraTL2 Moderator6 Jul 2026#19

Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.

32 likes 22d

batchlogTL3Regular7 Jul 2026#20

g.radich, post #15: post #14 answers the question as asked. The question underneath it is different. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your clinician is prudent if the gap is weeks or longer. Go to post

Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.

0 likes in reply to #15 21d

BramleyTL2Member7 Jul 2026#21

On post #17 — agreed on the reasoning, with one qualification.

Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.

7 likes 21d

r.chukwuTL2 Moderator8 Jul 2026#22

post #21 answers the question as asked. The question underneath it is different.

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

1 like 20d

c.niemelTL3Regular8 Jul 2026#23

Bramley, post #21: On post #17 — agreed on the reasoning, with one qualification. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice. Go to post

Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration discussion with a clinician.

0 likes in reply to #21 20d

n.dziedzicTL2 Moderator8 Jul 2026#24

Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for planning.

24 likes 19d

isotonic_driftTL1Member9 Jul 2026 · edited#25

Worth separating two things that post #21 runs together.

Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.

11 likes 19d

m.ndiayeTL2 Moderator9 Jul 2026#26

Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.

3 likes 19d

cohort_driftTL3Regular10 Jul 2026#27

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

0 likes in reply to #1 18d

s.okonkwoTL2 Moderator10 Jul 2026#28

International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is prudent if you can.

32 likes 18d

s.rasmussenTL2 Moderator11 Jul 2026#29

Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.

1 like 17d

l.trevinoTL2 Moderator11 Jul 2026#30

0 likes 17d

Sponsored Janoshik Analytical — independent third-party testingHPLC purity and mass-spectrometric identity on submitted samples, reported with the method stated. The laboratory most often cited in this community’s verification records.Independent testing → Sponsored GL Biochem (Shanghai) Ltd. — synthesis, directFounded 1998. ISO 9001 and cGMP certified, over 1,500 staff and 200-plus patents. Custom peptide synthesis and amino acid derivatives, with a batch certificate on every order.Custom synthesis →